We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$16.5B
AUM Growth
+$861M
Cap. Flow
+$217M
Cap. Flow %
1.32%
Top 10 Hldgs %
30.08%
Holding
735
New
44
Increased
335
Reduced
212
Closed
49

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$60.1M
2
QCOM icon
Qualcomm
QCOM
+$53.4M
3
NU icon
Nu Holdings
NU
+$48.5M
4
AMZN icon
Amazon
AMZN
+$46.5M
5
BMA icon
Banco Macro
BMA
+$43.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$40.8M
2
ADBE icon
Adobe
ADBE
+$36.1M
3
VIPS icon
Vipshop
VIPS
+$33.1M
4
SBUX icon
Starbucks
SBUX
+$31.4M
5
LOW icon
Lowe's Companies
LOW
+$29.1M

Sector Composition

Rank Sector Weight
1 Technology 33%
2 Healthcare 27.47%
3 Financials 9.69%
4 Consumer Discretionary 7.72%
5 Industrials 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARGX icon
151
argenx
ARGX
$57.4B
$22.1M 0.13%
51,418
+13,265
+35% +$5.08M
IDYA icon
152
IDEAYA Biosciences
IDYA
$3.41B
$22.1M 0.13%
629,019
-1,000
-0.2% -$39.6K
ZBRA icon
153
Zebra Technologies
ZBRA
$12.4B
$22M 0.13%
71,378
-353
-0.5% -$107K
PFE icon
154
Pfizer
PFE
$140B
$21.7M 0.13%
775,597
-532,565
-41% -$14.7M
LW icon
155
Lamb Weston
LW
$6.82B
$21.7M 0.13%
257,953
-4,802
-2% -$410K
NTRA icon
156
Natera
NTRA
$37.5B
$21.7M 0.13%
200,007
-28,001
-12% -$2.84M
RVMD icon
157
Revolution Medicines
RVMD
$40.2B
$21.5M 0.13%
554,334
-29,616
-5% -$1.11M
ILMN icon
158
Illumina
ILMN
$29.4B
$21.4M 0.13%
205,043
+10,998
+6% +$1.23M
MOH icon
159
Molina Healthcare
MOH
$10.3B
$21.2M 0.13%
71,285
+67,004
+1,565% +$22.7M
CLH icon
160
Clean Harbors
CLH
$16.1B
$21.1M 0.13%
93,259
-32,924
-26% -$6.9M
BSY icon
161
Bentley Systems
BSY
$9.54B
$21M 0.13%
425,009
+84,292
+25% +$4.37M
APLS
162
DELISTED
Apellis Pharmaceuticals
APLS
$20.8M 0.13%
543,035
-41,890
-7% -$1.9M
UTHR icon
163
United Therapeutics
UTHR
$26.3B
$20.5M 0.12%
64,513
+61,573
+2,094% +$16.3M
BRKR icon
164
Bruker
BRKR
$9.2B
$20.5M 0.12%
321,205
+220,278
+218% +$16.6M
SRPT icon
165
Sarepta Therapeutics
SRPT
$1.66B
$20.4M 0.12%
129,000
-22,000
-15% -$2.83M
XENE icon
166
Xenon Pharmaceuticals
XENE
$6.32B
$20.3M 0.12%
521,836
-39,048
-7% -$1.56M
KROS icon
167
Keros Therapeutics
KROS
$199M
$20.2M 0.12%
441,855
-210,144
-32% -$11.3M
WELL icon
168
Welltower
WELL
$178B
$20M 0.12%
191,716
+2,855
+2% +$280K
SNDX icon
169
Syndax Pharmaceuticals
SNDX
$1.84B
$19.9M 0.12%
970,106
-74,926
-7% -$1.57M
NUVL
170
DELISTED
Nuvalent
NUVL
$19.9M 0.12%
262,008
-22,001
-8% -$1.56M
SWTX
171
DELISTED
SpringWorks Therapeutics
SWTX
$19.7M 0.12%
522,104
+321,476
+160% +$13.5M
MAR icon
172
Marriott International
MAR
$98.7B
$19.6M 0.12%
80,949
+7,491
+10% +$1.8M
GE icon
173
GE Aerospace
GE
$367B
$19.4M 0.12%
122,331
-13,165
-10% -$2.1M
WMT icon
174
Walmart Inc
WMT
$871B
$19.3M 0.12%
284,575
-8,721
-3% -$549K
APO icon
175
Apollo Global Management
APO
$70.7B
$19.2M 0.12%
163,002
+11,866
+8% +$1.35M
5 6
7
8 9

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2024 Portfolio in Review

As of Q2 2024, Candriam SCA held 735 positions worth $16.5B, up 5.5% from $15.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q2 2024 filing shows 44 new, 335 increased, 212 reduced and 49 closed positions. Its largest new stake was Banco Macro: 754,200 shares worth $43.2M. The largest sale was Apple, an estimated $40.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2024 buy was Banco Macro: 754,200 shares worth $43.2M.
  • Candriam SCA added most to Eli Lilly in Q2 2024, an estimated $60.1M increase.
  • Candriam SCA's biggest Q2 2024 reduction was Apple, cutting an estimated $40.8M.
  • Candriam SCA fully exited Alpine Immune Sciences Inc in Q2 2024, selling an estimated $16.5M.
  • Candriam SCA's ten largest holdings make up 30% of its $16.5B portfolio in Q2 2024.
  • Candriam SCA opened 44 new positions and closed 49 in Q2 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $16.5B.

Based on Candriam SCA's 13F filing for Q2 2024, filed 5 Aug 2024.